|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 3/00 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 3362477 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16785072.6 |
| Date of filing the European patent application | 2016-10-11 | |
| (97) | Date of publication of the European application | 2018-08-22 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-05 |
| (46) | Date of publication of the claims translation | 2022-03-10 |
| (86) | Number | PCT/US2016/056465 |
| Date | 2016-10-11 |
| (87) | Number | WO 2017/066204 |
| Date | 2017-04-20 |
| (30) | Number | Date | Country code |
| 201562240021 P | 2015-10-12 | US | |
| 201662359757 P | 2016-07-08 | US | |
| 201662375495 P | 2016-08-16 | US | |
| 201662393143 P | 2016-09-12 | US |
| (72) |
GROMADA, Jesper , US
STEVIS, Panayiotis , US
ALTAREJOS, Judith , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antigenus surišantys baltymai, kurie aktyvuoja leptino receptorių |
| ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 10 | 231.00 EUR |
| 2026-10-11 |